Skip to main content
. 2016 Feb 11;7(12):13680–13687. doi: 10.18632/oncotarget.7322

Table 2. Decrease in the number of target lesions by adopting the RECIST 1.1.

Reference Tumor type No. of patients
Loss of target lesion Reduction of target lesions Causes of reduction No. of patients
Nishino et al. [19] NSCLC 3 22 LN criteria
Maximum no. of target lesions
18
4
Nishino et al. [20] NSCLC 2 31 LN criteria
Maximum no. of target lesions
Both
24
1
6
Ruan et al. [21] TC 0 8 LN criteria
Maximum no. of target lesions
Both
1
5
2
Krajewski et al. [23] RCC 3 43 LN criteria
Maximum no. of target lesions
Both
10
27
6
HHS Vulnerability Disclosure